参考文献/References:
[1] Vahanian A,Beyersdorf F,Praz F,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J,2022,43(7):561-632.
[2] Hagar A,Li Y,Wei X,et al. Incidence,predictors,and outcome of paravalvular leak after transcatheter aortic valve implantation[J]. J Interv Cardiol,2020,2020:1-11.
[3] Lázaro C,Hinojar R,Zamorano JL. Cardiac imaging in prosthetic paravalvular leaks[J]. Cardiovasc Diagn Ther,2014,4(4):307-313.
[4] Welle GA,El-Sabawi B,Thaden JJ,et al. Effect of eliminating pre-discharge transthoracic echocardiogram on outcomes after TAVR[J]. Catheter Cardiovasc Interv,2022,99(3):861-866.
[5] Généreux P,Piazza N,Alu MC,et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research[J]. Eur Heart J,2021,42(19):1825-1857.
[6] Mauri V,Frohn T,Deuschl F,et al. Impact of device landing zone calcification patterns on paravalvular regurgitation after transcatheter aortic valve replacement with different next-generation devices[J]. Open Heart,2020,7(1):e001164.
[7] Kofler M,Meyer A,Schwartz J,et al. A new calcium score to predict paravalvular leak in transcatheter aortic valve implantation[J]. Eur J Cardiothorac Surg,2021,59(4):894-900.
[8] Matta A,Regueiro A,Urena M,et al.Comparison of paravalvular leak in SAPIEN 3 and EVOLUT PRO valves in transcatheter aortic valve replacement: a multicenter registry[J]. Am J Cardiol,2023,207:114-120.
[9] Sherif MA,Abdel-Wahab M,St?cker B,et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis[J].J Am Coll Cardiol,2010,56(20):1623-1629.
[10] Jilaihawi H,Chin D,Spyt T,et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-Corevalve bioprosthesis[J].Eur Heart J,2009,31(7):857-864.
[11] Détaint D,Lepage L,Himbert D,et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve implantation[J]. JACC Cardiovasc Interv,2009,2(9):821-827.
[12] Tang GHL,Zaid S,George I,et al. Impact of aortic root anatomy and geometry on paravalvular leak in transcatheter aortic valve replacement with extremely large annuli using the edwards SAPIEN 3 valve[J]. JACC Cardiovasc Interv,2018,11(14):1377-1387.
[13] Tang GHL,Zaid S,Schnittman SR,et al. Novel predictors of mild paravalvular aortic regurgitation in SAPIEN 3 transcatheter aortic valve implantation[J]. EuroIntervention,2018,14(1):58-68.
[14] Kananathan S,Perera LA,Mohanarajan M,et al. The management of paravalvular leaks post aortic valve replacement[J]. J Card Surg,2022,37(9):2786-2798.
[15] Harrison JK,Hughes GC,Reardon MJ,et al. Balloon post-dilation following implantation of a self-expanding transcatheter aortic valve?bioprosthesis[J]. JACC Cardiovasc Interv, 2017 ,10(2):168-175.
[16] Renker M,Kim WK. Choice of transcatheter heart valve: should we select the device according to each patient’s characteristics or should it be “one valve fits all”?[J].Ann Transl Med,2020,8(15):961.
[17] Rheude T,Pellegrini C,Lutz J,et al. Transcatheter aortic valve replacement with balloon-expandable valves:comparison?of?SAPIEN?3 ultra versus SAPIEN 3[J]. JACC Cardiovasc Interv,2020,13(22):2631-2638.
[18] Popma JJ,Deeb GM,Yakubov SJ,et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients[J]. N Engl J Med,2019,380(18):1706-1715.
[19] Mack MJ,Leon MB,Thourani VH,et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients[J].N Engl J Med,2019,380(18):1695-1705.
[20] Borger MA,Fedak PWM,Stephens EH,et al. The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve–related aortopathy:full online-only version[J]. J Thorac Cardiovasc Surg,2018,156(2):e41-e74.
[21] Sievers HH,Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens[J]. J Thorac Cardiovasc Surg,2007,133(5):1226-1233.
[22] Zhang Y,Xiong TY,Li YM,et al. Patients with bicuspid aortic stenosis undergoing transcatheter aortic valve replacement:a systematic review and meta-analysis[J]. Front Cardiovasc Med,2022,9:794850.
[23] Jin Q,Li W,Chen S,et al. Aortic valve morphology and paravalvular leak regression after a self-expandable transcatheter aortic valve replacement[J]. Front Physiol,2023,13:1088681.
[24] Forrest JK,Kaple RK,Ramlawi B,et al. Transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valves from?the?STS/ACC TVT registry[J]. JACC Cardiovasc Interv,2020,13(15):1749-1759.
[25] Makkar RR,Yoon SH,Leon MB,et al. Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke[J]. JAMA ,2019,321(22):2193-2202.
[26] Heidari B,Al-Hijji MA,Alkhouli MA,et al. Transcatheter aortic valve replacement outcomes in mixed aortic valve disease compared to predominant aortic stenosis[J]. Int J Cardiol,2020,299:209-214.
[27] Sato K,Kumar A,Jones BM,et al. Reversibility of cardiac function predicts outcome after transcatheter aortic valve replacement in patients with severe aortic stenosis[J]. J Am Heart Assoc,2017,6(7):e005798.
[28] Abdelghani M,Cavalcante R,Miyazaki Y,et al. Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease[J]. EuroIntervention,2017,13(10):1157-1165.
[29] Seeger J,Gonska B,M?rike J,et al. Outcome of patients with mixed aortic valve disease undergoing transfemoral aortic valve replacement[J]. Struct Hear,2017,1:162-167.
[30] Lopez-Pais J,Lopez-Otero D,Garcia-Touchard A,et al. Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality[J]. Heart,2021,107(6):497-502.
[31] Okuno T,Tomii D,Heg D,et al. Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation[J]. EuroIntervention,2022,18(1):33-42.
相似文献/References:
[1]于子凯 许海燕 刘庆荣 吴永健.合并常见疾病对经导管主动脉瓣置换术患者预后的影响[J].心血管病学进展,2019,(5):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
YU Zikai,XU Haiyan,LIU Qingrong,et al.Influence of ommon Accompanied Diseases on Prognosis of Patients after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2019,(6):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
[2]邵美华 周玉强 王萌萌 王宝珠 马翔.经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄研究进展[J].心血管病学进展,2020,(11):1184.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[3]刘新民 宋光远 吴永健.左心室导丝起搏技术在经导管主动脉瓣置换术中的应用[J].心血管病学进展,2021,(4):289.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.001]
LIU Xinmin,SONG Guangyuan,WU Yongjian.Application of Left Ventricular Guidewire Pacing in Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2021,(6):289.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.001]
[4]李宗泽 何贵均 郑晓菲 蒋晖 刘汉雄.经导管主动脉瓣置换术后合并心房颤动的抗栓策略[J].心血管病学进展,2021,(10):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
LI ZongzeHE GuijunZHENG XiaofeiJIANG HuiLIU Hanxiong.Optimal Antithrombotic Strategies after Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(6):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
[5]陈阳 赵庆豪 赵杰 吴永健.经导管主动脉瓣置换术时代慢性主动脉瓣反流诊治进展[J].心血管病学进展,2022,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.001]
CHEN Yang,ZHAO Qinghao,SONG Guangyuan,et al.Diagnosis and Treatment of Chronic Aortic Regurgitation in Transcatheter Aortic Valve Replacement Era[J].Advances in Cardiovascular Diseases,2022,(6):1.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.001]
[6]董一娜 雷芳芳 宋启煦 王晶 杨艳.经导管主动脉瓣置换术后死亡风险预测模型系统评价[J].心血管病学进展,2022,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
DONG Yina,LEI Fangfang,SONG Qixu,et al.Mortality Risk Prediction Models After Transcatheter?span>Aortic Valve Replacement:A Systematic Review[J].Advances in Cardiovascular Diseases,2022,(6):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
[7]张木馨 李丽英 阮海燕 何森.经导管主动脉瓣置换术后抗栓治疗进展[J].心血管病学进展,2022,(6):518.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.010]
ZHANG Muxin,LI Liying,RUAN Haiyan,et al.Progress of Antithrombotic Therapy after?ranscatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(6):518.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.010]
[8]. 经导管主动脉瓣置换术术后抗栓治疗的研究进展 [J].心血管病学进展,2022,(7):577.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
DUAN ZhenyaWU Yongjian.Antithrombotic Therapy After Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2022,(6):577.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[9]王卫卫 于子凯 吴永健 许海燕 刘庆荣.序贯综合心脏康复模式在经导管主动脉瓣置换术患者中应用现状[J].心血管病学进展,2022,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
WANG Weiwei,YU Zikai,WU YongjianXU HaiyanLIU Qingrong.The Status of Sequential Comprehensive Cardiac Rehabilitation in Patients?ndergoing Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(6):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
[10]张航 安景辉 石凤梧.极简式经导管主动脉瓣置换术的研究现状[J].心血管病学进展,2022,(9):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
ZHANG Hang,AN Jinghui,SHI Fengwu.Minimalist Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(6):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]